BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 23026649)

  • 1. Clinical approach to splanchnic vein thrombosis: risk factors and treatment.
    Riva N; Donadini MP; Dentali F; Squizzato A; Ageno W
    Thromb Res; 2012 Oct; 130 Suppl 1():S1-3. PubMed ID: 23026649
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Splanchnic vein thrombosis: new risk factors and management.
    Donadini MP; Dentali F; Ageno W
    Thromb Res; 2012 Apr; 129 Suppl 1():S93-6. PubMed ID: 22682143
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcome of patients with splanchnic venous thrombosis presenting without overt MPN: a role for the JAK2 V617F mutation re-evaluation.
    Colaizzo D; Amitrano L; Guardascione MA; Tiscia GL; D'Andrea G; Longo VA; Grandone E; Margaglione M
    Thromb Res; 2013 Aug; 132(2):e99-e104. PubMed ID: 23916380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer-associated splanchnic vein thrombosis: Clinical implications and management considerations.
    Cohen O; Caiano LM; Levy-Mendelovich S
    Thromb Res; 2024 Feb; 234():75-85. PubMed ID: 38183815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Splanchnic vein thrombosis].
    Lajzová S; Kroupa R; Buliková A; Bohatá Š; Packová B; Šenkyřík M
    Vnitr Lek; 2018; 64(3):272-279. PubMed ID: 29766730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. JAK2 V617F-positive latent essential thrombocythemia and splanchnic vein thrombosis: the role of bone marrow biopsy for the diagnosis of myeloproliferative disease.
    Allegra A; Alonci A; Penna G; D'Angelo A; Rizzotti P; Granata A; Musolino C
    Acta Haematol; 2009; 121(4):218-20. PubMed ID: 19478480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term Clinical Outcomes of Splanchnic Vein Thrombosis: Results of an International Registry.
    Ageno W; Riva N; Schulman S; Beyer-Westendorf J; Bang SM; Senzolo M; Grandone E; Pasca S; Di Minno MN; Duce R; Malato A; Santoro R; Poli D; Verhamme P; Martinelli I; Kamphuisen P; Oh D; D'Amico E; Becattini C; De Stefano V; Vidili G; Vaccarino A; Nardo B; Di Nisio M; Dentali F
    JAMA Intern Med; 2015 Sep; 175(9):1474-80. PubMed ID: 26168152
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clonal populations of hematopoietic cells with paroxysmal nocturnal hemoglobinuria phenotype in patients with splanchnic vein thrombosis.
    Ageno W; Dentali F; De Stefano V; Barco S; Lerede T; Bazzan M; Piana A; Santoro R; Duce R; Poli D; Martinelli I; Siragusa S; Barillari G; Cattaneo M; Vidili G; Carpenedo M; Rancan E; Giaretta I; Tosetto A
    Thromb Res; 2014 Jun; 133(6):1052-5. PubMed ID: 24731559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antithrombotic treatment of splanchnic vein thrombosis: results of an international registry.
    Ageno W; Riva N; Schulman S; Bang SM; Sartori MT; Grandone E; Beyer-Westendorf J; Barillari G; Di Minno MN; Dentali F;
    Semin Thromb Hemost; 2014 Feb; 40(1):99-105. PubMed ID: 24381147
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic factors in noncirrhotic patients with splanchnic vein thromboses.
    Amitrano L; Guardascione MA; Scaglione M; Pezzullo L; Sangiuliano N; Armellino MF; Manguso F; Margaglione M; Ames PR; Iannaccone L; Grandone E; Romano L; Balzano A
    Am J Gastroenterol; 2007 Nov; 102(11):2464-70. PubMed ID: 17958760
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of Splanchnic Vein Thrombosis on Survival: 15-Year Institutional Experience With 1561 Cases.
    Wells PS; Theberge I; Bowdridge J; Kelly E; Kielar A; Forgie MA; John S; van Walraven C
    J Am Heart Assoc; 2020 Dec; 9(24):e016600. PubMed ID: 33269616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer-Associated Splanchnic Vein Thrombosis.
    Cohen O; Caiano LM; Tufano A; Ageno W
    Semin Thromb Hemost; 2021 Nov; 47(8):931-941. PubMed ID: 34116580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Splanchnic vein thrombosis in myeloproliferative neoplasms.
    Sekhar M; McVinnie K; Burroughs AK
    Br J Haematol; 2013 Sep; 162(6):730-47. PubMed ID: 23855810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Splanchnic Vein Thrombosis: Current Perspectives.
    Valeriani E; Riva N; Di Nisio M; Ageno W
    Vasc Health Risk Manag; 2019; 15():449-461. PubMed ID: 31695400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes during anticoagulation in patients with symptomatic vs. incidental splanchnic vein thrombosis.
    Tufano A; Ageno W; Di Micco P; Niglio A; Rosa V; Ballaz A; Braester A; Rubio CM; Isern V; Imbalzano E; Monreal M;
    Thromb Res; 2018 Apr; 164():69-74. PubMed ID: 29499439
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Splanchnic vein thrombosis and myeloproliferative neoplasms: molecular-driven diagnosis and long-term treatment.
    De Stefano V; Qi X; Betti S; Rossi E
    Thromb Haemost; 2016 Jan; 115(2):240-9. PubMed ID: 26333846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk factors of thrombosis in abdominal veins.
    Dutta AK; Chacko A; George B; Joseph JA; Nair SC; Mathews V
    World J Gastroenterol; 2008 Jul; 14(28):4518-22. PubMed ID: 18680232
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How to manage splanchnic vein thrombosis in patients with liver disease.
    Riva N; Ageno W
    Hematology Am Soc Hematol Educ Program; 2023 Dec; 2023(1):281-288. PubMed ID: 38066910
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How I treat splanchnic vein thrombosis.
    Ageno W; Dentali F; Squizzato A
    Blood; 2014 Dec; 124(25):3685-91. PubMed ID: 25320239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Superficial vein thrombosis: risk factors, diagnosis, and treatment.
    Marchiori A; Mosena L; Prandoni P
    Semin Thromb Hemost; 2006 Oct; 32(7):737-43. PubMed ID: 17024602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.